Silence Therapeutics plc Accumulated Other Comprehensive Income
Silence Therapeutics plc (SLNCF) had Accumulated Other Comprehensive Income of -$3.34 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-10
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.34M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.37M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.98M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.07M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$3.34M 10-Q · filed 2026-08-10 |
| 2026-03-31 | -$3.37M 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$2.98M 10-Q · filed 2026-08-10 |
| 2025-09-30 | -$3.07M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$1.40M 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$8.08M 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$11.78M 10-K · filed 2026-03-05 |
| 2023-12-31 | -$10.72M 10-K · filed 2025-02-27 |